Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Squill Oxymel, a traditional formulation from Drimia Maritima (L.) Stearn, as an add-on treatment in patients with moderate to severe persistent asthma: A pilot, triple-blind, randomized clinical trial.
Nejatbakhsh F, Karegar-Borzi H, Amin G, Eslaminejad A, Hosseini M, Bozorgi M, Gharabaghi MA. Nejatbakhsh F, et al. Among authors: eslaminejad a. J Ethnopharmacol. 2017 Jan 20;196:186-192. doi: 10.1016/j.jep.2016.12.032. Epub 2016 Dec 18. J Ethnopharmacol. 2017. PMID: 27998692 Clinical Trial.
An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial.
Mohammadi-Araghi M, Eslaminejad A, Karegar-Borzi H, Mazloomzadeh S, Nejatbakhsh F. Mohammadi-Araghi M, et al. Among authors: eslaminejad a. Evid Based Complement Alternat Med. 2022 May 30;2022:5024792. doi: 10.1155/2022/5024792. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35677368 Free PMC article.
Work-related exacerbation of asthma among adults treated by pulmonary specialists.
Sadeghniiat-Haghighi K, Aminian O, Najafi A, Salehpour S, Eslaminejad A, Derakhshan Deilami G, Nourijelyani K, Tarlo SM. Sadeghniiat-Haghighi K, et al. Among authors: eslaminejad a. Arch Environ Occup Health. 2016;71(1):35-42. doi: 10.1080/19338244.2014.941094. Epub 2014 Aug 20. Arch Environ Occup Health. 2016. PMID: 25141209
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Dastan F, et al. Among authors: eslaminejad a. Int Immunopharmacol. 2020 Nov;88:106869. doi: 10.1016/j.intimp.2020.106869. Epub 2020 Aug 4. Int Immunopharmacol. 2020. PMID: 32889241 Free PMC article. Clinical Trial.
34 results